Dje, what kind of news you are expecting about PBT2?
IMO the possibilities are:
1. Cardiac Light Chain Amyloidosis ( Diomede et al, 2017 ) related activity (phase 2, perhaps orphan disease application)
2. Co-operation with Queensland university about treating antibiotic-resistant infections ( human and food industry )
3. Possible deal with the new big pharma co-operation to target development of new antibiotics
4. Covid-19 related news, PBT2 possibilities to kill viruses
5. patent-related news, related to the above issues
6. else
end of the downside- back in, page-91
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.28M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $5.012K | 1.294M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 43 | 54662006 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 126993867 | 29 |
View Market Depth
| Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |